Skip to content
2000
Volume 1, Issue 3
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

Certain anti-cancer prodrugs are subject to cytochrome P450 (CYP)-mediated metabolism and become more active. Because CYP activity may be regulated by phosphorylation via adenylyl cyclase/protein kinase A, selective adenylyl cyclase subtype activators may be utilized in future chemotherapy to regulate CYP activity as a switch in a tumor tissue-specific manner.

Loading

Article metrics loading...

/content/journals/dml/10.2174/187231207781369744
2007-08-01
2025-12-23
Loading full text...

Full text loading...

/content/journals/dml/10.2174/187231207781369744
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test